OptiMedica names new vice president of regulatory, clinical and quality

US-based ophthalmic company OptiMedica has appointed Alan Marquardt to the newly created position of vice president, regulatory, clinical and quality.

Mr Marquardt joins OptiMedica following a 27 year career that included officer-level regulatory, clinical and quality affairs positions at companies including Sanarus Medical, Kyphon, Guidant, UroQuest Medical, EP Technologies/Boston Scientific, Schneider US Stent/Pfizer and Medtronic.

Mark Forchette, president and CEO of OptiMedica, said: "Alan joins OptiMedica at a very busy and exciting time, as we continue to expand the clinical science supporting our Pascal photocoagulator technology while also aggressively growing and diversifying our product portfolio.

"His vast regulatory, clinical and quality affairs experience in both domestic and international medical device markets will be instrumental in helping us achieve significant and responsible growth with our current commercial portfolio, and his expertise will prepare us to participate in significant new ophthalmic segments in the future."

http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon

Related terms: career, ceo, clinical, commercial, medical, president, science, technology